Late-onset symptomatic hyperprolactinemia in 6-pyruvoyl-tetrahydropterin synthase deficiency

Abstract Background Tetrahydrobiopterin (BH4) deficiency caused by 6-pyruvoyl-tetrahydropterin synthase (PTPS) deficiency is a rare disorder that is one of the major causes of hyperphenylalaninemia in Taiwan. Methods In this study, we reviewed the clinical courses of 12 adolescent and adult patients...

Full description

Bibliographic Details
Main Authors: Rai-Hseng Hsu, Ni-Chung Lee, Hui-An Chen, Wuh-Liang Hwu, Tung-Ming Chang, Yin-Hsiu Chien
Format: Article
Language:English
Published: BMC 2023-11-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Online Access:https://doi.org/10.1186/s13023-023-02963-4
_version_ 1797629984620150784
author Rai-Hseng Hsu
Ni-Chung Lee
Hui-An Chen
Wuh-Liang Hwu
Tung-Ming Chang
Yin-Hsiu Chien
author_facet Rai-Hseng Hsu
Ni-Chung Lee
Hui-An Chen
Wuh-Liang Hwu
Tung-Ming Chang
Yin-Hsiu Chien
author_sort Rai-Hseng Hsu
collection DOAJ
description Abstract Background Tetrahydrobiopterin (BH4) deficiency caused by 6-pyruvoyl-tetrahydropterin synthase (PTPS) deficiency is a rare disorder that is one of the major causes of hyperphenylalaninemia in Taiwan. Methods In this study, we reviewed the clinical courses of 12 adolescent and adult patients (7 females and 5 males) with PTPS deficiency. Results The patients were treated shortly after diagnosis through newborn screening with a combination of BH4, levodopa/carbidopa, and 5-OH-tryptophan. Their plasma phenylalanine and tyrosine levels were well controlled, and their prolactin levels were also decreased after treatment. However, their prolactin levels gradually rose as they grew into puberty, and at a current age of 27.5 [interquartile range (IQR 7.9)] years, five of the 12 patients had either highly elevated prolactin levels (> 100 ng/mL in one male patient, normal reference values, male < 11 ng/mL, female < 17 ng/mL) or symptoms, including irregular menstruation, amenorrhea, and breast swelling (in four female patients). The dosage of levodopa in these five patients (14.3 (IQR 3.0) mg/kg/day) was slightly higher than that in the other patients (p = 0.05). Magnetic resonance imaging studies did not reveal an increase in the size of the anterior pituitary gland, although a Rathke cleft cyst was found in one patient. Two patients received cabergoline treatment, which promptly lowered prolactin levels and relieved symptoms. Conclusions Hyperprolactinemia is common in female patients with PTPS deficiency, especially after puberty. A long-acting dopamine agonist, such as cabergoline, may be a necessary adjunctive treatment for most patients with BH4 deficiency.
first_indexed 2024-03-11T11:01:36Z
format Article
id doaj.art-d898d3715bb7457cb12fc0c21b3d1e54
institution Directory Open Access Journal
issn 1750-1172
language English
last_indexed 2024-03-11T11:01:36Z
publishDate 2023-11-01
publisher BMC
record_format Article
series Orphanet Journal of Rare Diseases
spelling doaj.art-d898d3715bb7457cb12fc0c21b3d1e542023-11-12T12:29:59ZengBMCOrphanet Journal of Rare Diseases1750-11722023-11-011811710.1186/s13023-023-02963-4Late-onset symptomatic hyperprolactinemia in 6-pyruvoyl-tetrahydropterin synthase deficiencyRai-Hseng Hsu0Ni-Chung Lee1Hui-An Chen2Wuh-Liang Hwu3Tung-Ming Chang4Yin-Hsiu Chien5Department of Pediatrics, National Taiwan University HospitalDepartment of Pediatrics, National Taiwan University HospitalDepartment of Pediatrics, National Taiwan University HospitalDepartment of Pediatrics, National Taiwan University HospitalDepartment of Pediatric Neurology, Changhua Christian Children’s HospitalDepartment of Pediatrics, National Taiwan University HospitalAbstract Background Tetrahydrobiopterin (BH4) deficiency caused by 6-pyruvoyl-tetrahydropterin synthase (PTPS) deficiency is a rare disorder that is one of the major causes of hyperphenylalaninemia in Taiwan. Methods In this study, we reviewed the clinical courses of 12 adolescent and adult patients (7 females and 5 males) with PTPS deficiency. Results The patients were treated shortly after diagnosis through newborn screening with a combination of BH4, levodopa/carbidopa, and 5-OH-tryptophan. Their plasma phenylalanine and tyrosine levels were well controlled, and their prolactin levels were also decreased after treatment. However, their prolactin levels gradually rose as they grew into puberty, and at a current age of 27.5 [interquartile range (IQR 7.9)] years, five of the 12 patients had either highly elevated prolactin levels (> 100 ng/mL in one male patient, normal reference values, male < 11 ng/mL, female < 17 ng/mL) or symptoms, including irregular menstruation, amenorrhea, and breast swelling (in four female patients). The dosage of levodopa in these five patients (14.3 (IQR 3.0) mg/kg/day) was slightly higher than that in the other patients (p = 0.05). Magnetic resonance imaging studies did not reveal an increase in the size of the anterior pituitary gland, although a Rathke cleft cyst was found in one patient. Two patients received cabergoline treatment, which promptly lowered prolactin levels and relieved symptoms. Conclusions Hyperprolactinemia is common in female patients with PTPS deficiency, especially after puberty. A long-acting dopamine agonist, such as cabergoline, may be a necessary adjunctive treatment for most patients with BH4 deficiency.https://doi.org/10.1186/s13023-023-02963-4Tetrahydrobiopterin deficiencyBH46-Pyruvoyl-tetrahydropterin synthase deficiencyPTPSHyperphenylalaninemiaHyperprolactinemia
spellingShingle Rai-Hseng Hsu
Ni-Chung Lee
Hui-An Chen
Wuh-Liang Hwu
Tung-Ming Chang
Yin-Hsiu Chien
Late-onset symptomatic hyperprolactinemia in 6-pyruvoyl-tetrahydropterin synthase deficiency
Orphanet Journal of Rare Diseases
Tetrahydrobiopterin deficiency
BH4
6-Pyruvoyl-tetrahydropterin synthase deficiency
PTPS
Hyperphenylalaninemia
Hyperprolactinemia
title Late-onset symptomatic hyperprolactinemia in 6-pyruvoyl-tetrahydropterin synthase deficiency
title_full Late-onset symptomatic hyperprolactinemia in 6-pyruvoyl-tetrahydropterin synthase deficiency
title_fullStr Late-onset symptomatic hyperprolactinemia in 6-pyruvoyl-tetrahydropterin synthase deficiency
title_full_unstemmed Late-onset symptomatic hyperprolactinemia in 6-pyruvoyl-tetrahydropterin synthase deficiency
title_short Late-onset symptomatic hyperprolactinemia in 6-pyruvoyl-tetrahydropterin synthase deficiency
title_sort late onset symptomatic hyperprolactinemia in 6 pyruvoyl tetrahydropterin synthase deficiency
topic Tetrahydrobiopterin deficiency
BH4
6-Pyruvoyl-tetrahydropterin synthase deficiency
PTPS
Hyperphenylalaninemia
Hyperprolactinemia
url https://doi.org/10.1186/s13023-023-02963-4
work_keys_str_mv AT raihsenghsu lateonsetsymptomatichyperprolactinemiain6pyruvoyltetrahydropterinsynthasedeficiency
AT nichunglee lateonsetsymptomatichyperprolactinemiain6pyruvoyltetrahydropterinsynthasedeficiency
AT huianchen lateonsetsymptomatichyperprolactinemiain6pyruvoyltetrahydropterinsynthasedeficiency
AT wuhlianghwu lateonsetsymptomatichyperprolactinemiain6pyruvoyltetrahydropterinsynthasedeficiency
AT tungmingchang lateonsetsymptomatichyperprolactinemiain6pyruvoyltetrahydropterinsynthasedeficiency
AT yinhsiuchien lateonsetsymptomatichyperprolactinemiain6pyruvoyltetrahydropterinsynthasedeficiency